Filing Details
- Accession Number:
- 0001669639-24-000001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 16:24:42
- Reporting Period:
- 2024-03-07
- Accepted Time:
- 2024-03-11 16:24:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 883984 | Icu Medical Inc | ICUI | Surgical & Medical Instruments & Apparatus (3841) | 330022692 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1669639 | Ruth Virginia Sanzone | 951 Calle Amanecer San Clemente CA 92673 | Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-07 | 1,073 | $0.00 | 5,751 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-07 | 587 | $105.39 | 5,164 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2024-03-07 | 6,436 | $0.00 | 11,600 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-07 | 3,529 | $105.39 | 8,071 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-03-08 | 3,300 | $104.57 | 4,771 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-08 | 2,273 | $0.00 | 7,044 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-08 | 1,246 | $104.52 | 5,798 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Disposition | 2024-03-07 | 1,073 | $0.00 | 1,073 | $0.00 |
| Common Stock | Common Stock | Acquisiton | 2024-03-08 | 9,568 | $0.00 | 9,568 | $0.00 |
| Common Stock | Performance Shares | Disposition | 2024-03-07 | 6,436 | $0.00 | 6,436 | $0.00 |
| Common Stock | Performance Shares | Disposition | 2024-03-08 | 2,273 | $0.00 | 2,273 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,073 | 2023-03-07 | 2025-03-07 | No | 4 | M | Direct |
| 9,568 | No | 4 | A | Direct | ||
| 0 | 2024-03-07 | No | 4 | M | Direct | |
| 0 | 2023-03-08 | 2024-03-08 | No | 4 | M | Direct |
Footnotes
- These securities are Restricted Stock Units.
- These Securities are Performance-based Restricted Stock Units (PRSU).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.54 to $104.84, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- There is neither a purchase price nor an exercise price for the Restricted Stock Units.
- One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
- These are restricted stock units that fully vest 3 years from the grant date.
- There is neither a purchase price nor an exercise price for the PRSUs.
- These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
- These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant.
Billionaire Hedge Funds
